Ledger. Australian venture funding, tracked

CEO, Molecule to Medicine

Kirsty McCarthy

Coverage

Stories naming Kirsty McCarthy. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Unnamed stage $1m

UQ biotech innovation partnership forges a second startup

UniQuest and Molecule to Medicine have formed Curlew Bio to develop anti-inflammatory drugs, backed by $1 million from UniQuest's Extension Fund; the article also recalls Novartis's 2015 purchase of Spinifex Pharmaceuticals.

Something wrong? Tell us